Trilantic's Doppel bolts on Dietopack

Trilantic said in a statement that the deal is the seventh add-on for its Germany and Italy-based healthcare portfolio companies in 2020. Its healthcare portfolio includes Germany-based clinic chain Oberberg Gruppe.

Trilantic supported the bolt-on of Dietopack with fresh equity.

Trilantic bought a majority stake in Doppel in July 2015. At the time, the company reported revenues of €83.4m and EBITDA of €12.3m. Trilantic deployed equity via Trilantic Capital Partners V Europe, which held a final close in June 2015 on €900m. The fund has made eight platform investments and has some remaining dry powder to pursue buy-and-build strategies. The vehicle made its latest platform investment in December 2019, when Trilantic acquired Germany-based Care Home Group.

The add-on aims to build on Doppel's R&D capabilities, since Doppel is Italy's second largest contract developing and manufacturing company, the GP said in a statement. The firm added that the industry has remained resilient to the coronavirus pandemic.

Company
Dietopack develops, manufactures and packages food supplements, including probiotics, vitamins, minerals and high protein dietary supplements in the form of tablets, powders and granules. The company was founded in 2000 and initially produced food supplement packaging until 2010, when it began to produce food supplements.

Based in Medolla, Emilia Romagna, the company has 60 employees and generates 80% of its revenues from its neutraceutical supplements, which it generally distributes via pharmacies.

People
Trilantic Europe – Vittorio Pignatti (chairman).
Dietopack – Cecilia Cavazzuti (CEO).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• Southern Europe
• Healthcare
• Build-up
• Acquisition finance
• Italy
• Trilantic Capital Partners (previously LBMB)